Classification of ductal carcinoma in situ of the breast

Advances in Anatomic Pathology

Volumn 3, Issue 2, 1996, Pages 114-129

  Millis, Rosemary R ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000486196     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-199603000-00020     Document Type: Review

References (43)

1. Millis RR, Hanby AM, Girling AC. The breast. In: Sternberg SS, ed. Diagnostic surgical pathology, 2nd ed. New York: Raven Press, 1994:323-407.
2. Foote F, Stewart F. Lobular carcinoma in situ, a rare form of mammary cancer. Am J Pathol 1941;17:491-7.
3. Rosner D, Bedwani R, Vana J, Baker H, Murphy G. Non-invasive breast carcinoma. Results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139-47.
4. Fentiman I, Fagg N, Mills R, Hayward J. In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol 1986;12:261-6.
5. Lagios M, Margolin F, Westdahl P, Rose M. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24.
6. Betsill Jr WL, Rosen P, Lieberman P, Robbins G. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 1978;239:1863-7.
7. Page D, Dupont W, Rogers L, Landenberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982;49:751-8.
8. Eusebi V, Foschini M, Cook M, Berrino F, Azzopardi J. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol 1989;6:165-73.
9. Patchefsky A, Schwartz G, Finkelstein G, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989;63:731-41.
10. van Dongen J, Holland R, Peterse J, et al. Ductal carcinoma in-situ of the breast: second EORTC consensus meeting. Eur J Cancer 1992;28:626-9.
11. Azzopardi J. Problems in breast pathology. Major problems in pathology, vol. 11. Philadelphia: W. B. Saunders, 1979:128-46.
12. Tavassoli F. Pathology of the breast. Norwalk: Appleton and Lange, 1992:229-91.
13. Rogers L. Carcinoma in situ (CIS). In: Page D, Anderson T, eds. Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone, 1987:157-92.
14. Lagios M. Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 1990;70:853-71.
15. Bellamy C, McDonald C, Salter D, Chetty U, Anderson T. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24:16-23.
16. Lennington W, Jensen R, Dalton L, Page D. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994;73:118-24.
17. Poller D, Silverstein M, Galea M, et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification, association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994;7:257-62.
18. Holland R, Peterse J, Millis R, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994;11:167-80.
19. Silverstein M, Poller D, Waisman J, et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 1995;345:1154-7.
20. National Coordinating Group for Breast Screening Pathology. Pathology reporting in breast cancer screening. 2nd ed. NHSBSP Publication No. 3. 1995.
21. Lagios M, Westdahl P, Margolin F, Rose M. Ductal carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases and short-term treatment failures. Cancer 1982;50:1309-14.
22. Ottesen G, Graversen H, Blichert-Toft M, Zedeler K, Andersen J. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. Am J Surg Pathol 1992;16:1183-96.
23. White J, Levine A, Gustafson G, et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:791-7.
24. Schwartz G, Finkel G, Garcia J, Patchefsky A. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 1992;70:2468-74.
25. Solin L, Yeh I-T, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 1993;71:2532-42.
26. Silverstein M, Cohlan B, Gierson E, et al. Ductal carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992;28:630-4.
27. Holland R, Hendricks J. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlations. Semin Diagn Pathol 1994;11:181-92.
28. Faverly D, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994;11:193-8.
29. Bobrow L, Happerfield L, Gregory W, Springall R, Millis R. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol 1994;11:199-207.
30. Zafrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal carcinoma in situ of the breast analyzed with a new classification. A study of 127 cases. Semin Diagn Pathol 1994;11:208-14.
31. Lampejo O, Barnes D, Smith P, Millis R. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol 1994;11:215-22.
32. Holland R, Hendriks J, Verbeek A, Mravunac M, Schuurmans Stekhoven J. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
33. Schwartz G, Patchefsky A, Finkelstein S, et al. Nonpalpable in situ ductal carcinoma of the breast. Predictors of multicentricity and microinvasion and implications for treatment. Arch Surg 1989;124:29-32.
34. Eusebi V, Feudale E, Foschini M, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994;11:223-35.
35. Lagios M. Heterogeneity of ductal carcinoma in situ of the breast. J Cell Biochem 1993;17G:49-52.
36. Fisher E, Costantino J, Fisher B, Palekar A, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-9.
37. Poller D, Ellis I. Ductal carcinoma in situ (DCIS) of the breast. In: Kirkhan N, Lemoine N, eds. Progress in pathology. Vol. 2. Edinburgh: Churchill Livingstone, 1995:47-87.
38. Recht A, van Dongen J, Fentiman I, Holland R, Peterse J. Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S Giorgio, Venezia, 28 February 1994) - Conference Report. Eur J Cancer 1994;30A:1895-901.
39. Silverstein M, Gierson E, Colburn W, et al. Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 1994;73:2985-9.
40. Arnesson L-G, Smeds S, Fagerberg G, Grontoft O. Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 1989;76:672-5.
41. Evans A, Pinder S, Wilson R, et al. Ductal carcinoma in situ of the breast. Correlations between mammographic and pathologic findings. AJR 1994;162:1307-11.
42. Page D, Lagios M. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Cancer 1995;75:1219-222.
43. Fisher E, Costantino J, Fisher B, Palekar A, Mamounas E. Response - blunting the counterpoint. Cancer 1995;75:1223-7.